Pulmonx (LUNG) Operating Income (2019 - 2025)
Pulmonx (LUNG) reported Operating Income of -$14.4 million for Q3 2025, down 1.87% year-over-year from -$14.7 million in Q3 2024, and up 2.78% quarter-over-quarter from -$14.8 million in Q2 2025.
Pulmonx (LUNG) Operating Income (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has 7 years of Operating Income data on file, last reported at -$14.4 million in Q3 2025.
- Operating Income for Q3 2025 came in at -$14.4 million, down 1.87% year-over-year; the trailing twelve-month figure through Sep 2025 was -$57.2 million (up 1.77% YoY), and the FY2024 annual result was -$57.7 million, up 6.83% from the prior year.
- Operating Income improved to -$14.4 million in Q3 2025 per LUNG's latest filing, from -$14.8 million in the prior quarter.
- Over five years, Operating Income peaked at -$9.8 million in Q3 2021 and troughed at -$16.4 million in Q2 2023.
- A 5-year average of -$14.2 million and a median of -$14.4 million in 2022 frame the typical range for Operating Income.
- The sharpest annual moves came in 2021 and 2024: Operating Income plunged 104.69% in 2021, then advanced 11.37% in 2024.
- A 5-year view of Operating Income shows it stood at -$12.4 million in 2021, then dropped by 18.28% to -$14.6 million in 2022, then gained by 4.84% to -$13.9 million in 2023, then rose by 3.61% to -$13.4 million in 2024, then fell by 7.27% to -$14.4 million in 2025.
- Business Quant data shows LUNG's Operating Income at -$14.4 million in Q3 2025, -$14.8 million in Q2 2025, and -$14.6 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.46 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 282.15 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 255.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 316.80 Mn |
| 10 | Pulmonx | 54.38 Mn | -15.37 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -14.39 Mn |
| Jun 30, 2025 | -14.80 Mn |
| Mar 31, 2025 | -14.56 Mn |
| Dec 31, 2024 | -13.42 Mn |
| Sep 30, 2024 | -14.13 Mn |
| Jun 30, 2024 | -15.62 Mn |
| Mar 31, 2024 | -14.54 Mn |
| Dec 31, 2023 | -13.92 Mn |
| Sep 30, 2023 | -15.18 Mn |
| Jun 30, 2023 | -16.44 Mn |
| Mar 31, 2023 | -16.40 Mn |
| Dec 31, 2022 | -14.63 Mn |
| Sep 30, 2022 | -13.93 Mn |
| Jun 30, 2022 | -14.41 Mn |
| Mar 31, 2022 | -15.67 Mn |
| Dec 31, 2021 | -12.37 Mn |
| Sep 30, 2021 | -9.76 Mn |
| Jun 30, 2021 | -12.68 Mn |
| Mar 31, 2021 | -12.49 Mn |
| Dec 31, 2020 | -9.35 Mn |